Bolt Biotherapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs.

CEO

William P. Quinn

CEOWilliam P. Quinn

Employees

Employees52

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2015

Founded2015

Employees

Employees52

BOLT Key Statistics

Market cap

11.43M

Market cap11.43M

Price-Earnings ratio

-0.18

Price-Earnings ratio-0.18

Dividend yield

—

Dividend yield—

Average volume

144.04K

Average volume144.04K

High today

$0.31

High today$0.31

Low today

$0.2895

Low today$0.2895

Open price

$0.2895

Open price$0.2895

Volume

135.04K

Volume135.04K

52 Week high

$0.8401

52 Week high$0.8401

52 Week low

$0.2895

52 Week low$0.2895

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.